Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Verisante Technology Inc. V.VRS


Primary Symbol: V.VER.H

Verisante Technology Inc is a Canada based medical device company. It is engaged in commercializing medical systems for the early detection of cancer. The products of the company are Verisante Aura which is for skin cancer detection and Verisante Core which is for lung, colon and cervical cancer detection. It utilizes a cancer detection platform while the operating software and probe technology. The group generates revenue from the sale and renting of its medical devices.


TSXV:VER.H - Post by User

Bullboard Posts
Comment by AnalyticalTraderon Oct 11, 2011 4:49pm
405 Views
Post# 19138538

RE: Adjustment to 0.70-0.75 expected

RE: Adjustment to 0.70-0.75 expectedDisclaimer: I already hold a position in the stock. For a successful maturation of the prices, long-term investors should, upon performing their due diligence, look to protect their positions. Over the past couple of weeks, we've seen an adjustment to both the prices and the temperament of the shareholders. These adjustments are significant for reading the prices intelligently. A solid base of support from shareholders can further capitalise on milestones and minimise unnecessary setbacks and negative adjustments. In my view it is better for shares to be held by long-term investors who clearly understand the direction and profitability of this Company. Once again, 2.6$ covers up to probably Q2 2012, and after all the initial milestones are reached we could expect VRS to perform at around the prices of its peers. That, I think, would be around $4-5 in 2012-3.
Bullboard Posts